Loading clinical trials...
Loading clinical trials...
In this project, we will examine individual differences in the effects of a stimulant drug, methamphetamine (MA), on mesolimbic reward function using fMRI.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Chicago
Collaborators
NCT06790576 · Stimulant Use Disorder
NCT05835921 · Stimulant Use, Substance Use Disorders
NCT06814275 · Stimulant Use, Human Immunodeficiency Virus (HIV), and more
NCT06444256 · Stimulant Use Disorder
NCT06474026 · Psychostimulant Use Disorder(PUD)
University of Chicago
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions